SMid Biotech Analyst Cheng holds a conference call with Kyverna’a Scientific Advisor Schett on June 17 at 12 pm hosted by JPMorgan.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYTX:
- After Kyverna data, Oppenheimer says Cartesian ‘can exploit’ CAR-T’s ‘baggage’
- Kyverna: KYV-101 demonstrates ‘promising’ outcomes across multiple indications
- Kyverna, Cabaletta selloffs an overreaction, says Wells Fargo
- Kyverna weakness after EULAR update ‘an overreaction,’ says JPMorgan
- Kyverna Therapeutics Inc trading resumes